Stock Research: ICU Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

ICU Medical

NasdaqGS:ICUI US44930G1076
43
  • Value
    51
  • Growth
    43
  • Safety
    Safety
    69
  • Combined
    63
  • Sentiment
    38
  • 360° View
    360° View
    43
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ICU Medical, Inc. develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care. The company operates in the medical devices industry and offers products such as IV pumps, connectors, and catheters. In the last fiscal year, the company had a market cap of $3,140 million, profits of $825 million, and revenue of $2,382 million with 15000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 43 (better than 43% compared with alternatives), overall professional sentiment and financial characteristics for the stock ICU Medical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for ICU Medical. The consolidated Value Rank has an attractive rank of 69, which means that the share price of ICU Medical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 69% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 51. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 38. Professional investors are more confident in 62% other stocks. The consolidated Growth Rank also has a low rank of 43, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 57 of its competitors have better growth. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
69 53 82 59
Growth
43 19 3 23
Safety
Safety
51 69 54 100
Sentiment
38 36 31 25
360° View
360° View
43 36 30 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
69 60 22 58
Opinions Change
50 50 50 50
Pro Holdings
n/a 63 44 19
Market Pulse
53 26 43 44
Sentiment
38 36 31 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
69 53 82 59
Growth
43 19 3 23
Safety Safety
51 69 54 100
Combined
63 38 35 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 44 69 56
Price vs. Earnings (P/E)
71 56 83 64
Price vs. Book (P/B)
79 73 85 68
Dividend Yield
1 1 1 1
Value
69 53 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
1 10 8 10
Profit Growth
63 13 19 40
Capital Growth
69 22 47 45
Stock Returns
39 85 23 63
Growth
43 19 3 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
30 40 22 87
Refinancing
61 49 71 59
Liquidity
43 59 55 94
Safety Safety
51 69 54 100

Similar Stocks

Discover high‑ranked alternatives to ICU Medical and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.